150 related articles for article (PubMed ID: 8105944)
21. Length of interdialytic interval influences serum calcium and phosphorus concentrations.
Sigrist MK; Devlin L; Taal MW; Fluck RJ; McIntyre CW
Nephrol Dial Transplant; 2005 Aug; 20(8):1643-6. PubMed ID: 15870223
[TBL] [Abstract][Full Text] [Related]
22. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
23. Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
Hsu SC; Lee YY; Wang MC; Liu HL; Cheng MF; Huang JJ
Blood Purif; 2004; 22(2):224-8. PubMed ID: 15044822
[TBL] [Abstract][Full Text] [Related]
24. Long-term studies using a calcium-free dialysate.
Kaye M
Clin Nephrol; 1993 Oct; 40(4):221-4. PubMed ID: 8261679
[TBL] [Abstract][Full Text] [Related]
25. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
26. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
27. Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.
Liang J; Wang Z; Liu G; Zhan J; Jiang L; Jiang Z
Ren Fail; 2014 Feb; 36(1):65-8. PubMed ID: 24028708
[TBL] [Abstract][Full Text] [Related]
28. [Hypercalcemia in a female patient with chronic kidney failure secondary to sarcoidosis: a metabolic study of the calcium metabolism and bone histology].
Caravaca F; Cubero JJ; de Francisco AL; Arrobas M; Pizarro JL; Sánchez-Casado E
Med Clin (Barc); 1991 May; 96(17):659-61. PubMed ID: 2056801
[TBL] [Abstract][Full Text] [Related]
29. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
30. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
Yaginuma T; Yamamoto H
Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
[TBL] [Abstract][Full Text] [Related]
31. Different routes bridging calcium in Japanese hemodialysis patients.
Hamano T; Fujii N; Ito T; Imai E
Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
[TBL] [Abstract][Full Text] [Related]
32. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
33. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients.
Bender FH; Bernardini J; Piraino B
Am J Kidney Dis; 1992 Oct; 20(4):367-71. PubMed ID: 1415205
[TBL] [Abstract][Full Text] [Related]
34. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
35. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Gotch F; Levin NW; Kotanko P
Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
[TBL] [Abstract][Full Text] [Related]
36. A mathematical model of regional citrate anticoagulation in hemodialysis.
Thijssen S; Kruse A; Raimann J; Bhalani V; Levin NW; Kotanko P
Blood Purif; 2010; 29(2):197-203. PubMed ID: 20093827
[TBL] [Abstract][Full Text] [Related]
37. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
38. Relationship between intraperitoneal bleeding, adhesions, and peritoneal dialysis catheter failure: a method of prevention.
Gadallah MF; Torres-Rivera C; Ramdeen G; Myrick S; Habashi S; Andrews G
Adv Perit Dial; 2001; 17():127-9. PubMed ID: 11510259
[TBL] [Abstract][Full Text] [Related]
39. Hemodialysis with high-calcium dialysate impairs cardiac relaxation.
Näppi SE; Saha HH; Virtanen VK; Mustonen JT; Pasternack AI
Kidney Int; 1999 Mar; 55(3):1091-6. PubMed ID: 10027948
[TBL] [Abstract][Full Text] [Related]
40. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
Montenegro J; Saracho R; González O; Moina I; Martínez I
Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
